Filed: 8/14/2026ACC: 0001993440-26-000004
📋 What this filing means
FIRST TURN MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 31 equity positions with a total reported market value of $934.72M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
31
Positions
$934.72M
Total AUM (reported)
14.97M
Total Shares
Allocation by class
COM$645.54M69.1%
SHS$75.15M8.0%
COM NEW$72.89M7.8%
SPONSORED ADS$65.28M7.0%
COM PAR $.01$28.13M3.0%
ORD SHS$27.97M3.0%
ORDINARY SHARES$19.74M2.1%
Portfolio Concentration
Top 3$196.52M21.0%
4–10$304.32M32.6%
11–25$368.69M39.4%
Rest$65.18M7.0%
Top 3 weight
21.0%
Top 10 weight
53.6%
Voting Authority Distribution
Total shares with voting rights: 14.97M
Sole
Full voting authority
14.97M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole31
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings31
Rows:
REVOLUTION MEDICINES INC
SOLEShares415.31K
TypeSH
Market value$77.78M
8.32%
Sole
415.31K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares489.89K
TypeSH
Market value$65.28M
6.98%
Sole
489.89K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC.
SOLEShares218.41K
TypeSH
Market value$53.46M
5.72%
Sole
218.41K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares954.36K
TypeSH
Market value$48.43M
5.18%
Sole
954.36K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares633.36K
TypeSH
Market value$47.17M
5.05%
Sole
633.36K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares1.33M
TypeSH
Market value$47.11M
5.04%
Sole
1.33M
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares84.93K
TypeSH
Market value$46.02M
4.92%
Sole
84.93K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares527.41K
TypeSH
Market value$44.93M
4.81%
Sole
527.41K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares600.20K
TypeSH
Market value$36.23M
3.88%
Sole
600.20K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares329.10K
TypeSH
Market value$34.43M
3.68%
Sole
329.10K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares1.67M
TypeSH
Market value$30.68M
3.28%
Sole
1.67M
Shared
0.00
None
0.00
INSMED INC
SOLEShares263.85K
TypeSH
Market value$28.13M
3.01%
Sole
263.85K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares608.92K
TypeSH
Market value$28.05M
3.00%
Sole
608.92K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares104.88K
TypeSH
Market value$27.97M
2.99%
Sole
104.88K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares83.53K
TypeSH
Market value$27.96M
2.99%
Sole
83.53K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares285.77K
TypeSH
Market value$27.86M
2.98%
Sole
285.77K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares443.84K
TypeSH
Market value$25.80M
2.76%
Sole
443.84K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares218.05K
TypeSH
Market value$25.53M
2.73%
Sole
218.05K
Shared
0.00
None
0.00
PALVELLA THERAPEUTICS INC NE
SOLEShares156.45K
TypeSH
Market value$23.91M
2.56%
Sole
156.45K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares602.28K
TypeSH
Market value$23.31M
2.49%
Sole
602.28K
Shared
0.00
None
0.00
ERASCA INC
SOLEShares1.22M
TypeSH
Market value$22.38M
2.39%
Sole
1.22M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares2.02M
TypeSH
Market value$21.85M
2.34%
Sole
2.02M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares582.50K
TypeSH
Market value$19.74M
2.11%
Sole
582.50K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares138.82K
TypeSH
Market value$18.43M
1.97%
Sole
138.82K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares154.02K
TypeSH
Market value$17.10M
1.83%
Sole
154.02K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REVOLUTION MEDICINES INCSOLE | COM | 415.31K | SH | $77.78M 8.32% | 415.31K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 489.89K | SH | $65.28M 6.98% | 489.89K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INC.SOLE | COM | 218.41K | SH | $53.46M 5.72% | 218.41K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 954.36K | SH | $48.43M 5.18% | 954.36K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 633.36K | SH | $47.17M 5.05% | 633.36K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 1.33M | SH | $47.11M 5.04% | 1.33M | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 84.93K | SH | $46.02M 4.92% | 84.93K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 527.41K | SH | $44.93M 4.81% | 527.41K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 600.20K | SH | $36.23M 3.88% | 600.20K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 329.10K | SH | $34.43M 3.68% | 329.10K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 1.67M | SH | $30.68M 3.28% | 1.67M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 263.85K | SH | $28.13M 3.01% | 263.85K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 608.92K | SH | $28.05M 3.00% | 608.92K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | ORD SHS | 104.88K | SH | $27.97M 2.99% | 104.88K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 83.53K | SH | $27.96M 2.99% | 83.53K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 285.77K | SH | $27.86M 2.98% | 285.77K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 443.84K | SH | $25.80M 2.76% | 443.84K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 218.05K | SH | $25.53M 2.73% | 218.05K | 0.00 | 0.00 |
PALVELLA THERAPEUTICS INC NESOLE | COM | 156.45K | SH | $23.91M 2.56% | 156.45K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 602.28K | SH | $23.31M 2.49% | 602.28K | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 1.22M | SH | $22.38M 2.39% | 1.22M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 2.02M | SH | $21.85M 2.34% | 2.02M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 582.50K | SH | $19.74M 2.11% | 582.50K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 138.82K | SH | $18.43M 1.97% | 138.82K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 154.02K | SH | $17.10M 1.83% | 154.02K | 0.00 | 0.00 |
Page 1 of 2